This week's Oncology digest · 2026-W24
This Week in Oncology: Muscle Loss, HCC Treatment, Breast Radiotherapy
PFS and ORR fall short as OS surrogates in metastatic RCC
Analysis shows limitations in using certain metrics to predict cancer survival
In metastatic RCC, PFS and ORR show only moderate correlation with OS, with surrogate thresholds that are not statistically significant.
A large analysis of kidney cancer cases suggests that common clinical markers may not reliably predict how long a patient will live.
PD-1/PD-L1 inhibitors with anti-angiogenic drugs achieve 48% ORR in recurrent or metastatic nasopharyngeal carcinoma
New drug combinations show promise for advanced nasopharyngeal cancer
This meta-analysis of 10 independent cohorts from 9 studies evaluates PD-1/PD-L1 inhibitors combined with small-molecule anti-angiogenic dru…
Combining certain immunotherapy drugs with anti-angiogenic agents shows a 48% response rate for patients with advanced nasopharyngeal cancer…
FOLFOXIRI plus cetuximab does not improve survival or response rates compared to bevacizumab in mCRC
Trial Shows No Difference Between Two Colorectal Cancer Treatments
This meta-analysis of 561 patients with metastatic colorectal cancer found no significant differences in overall survival, progression-free …
A review of 561 patients found no difference in survival or response rates between two common drug combinations for metastatic colorectal ca…
Home-based exercise rehabilitation may improve cardiorespiratory fitness and quality of life in cancer
Home exercise programs may improve fitness for people with cancer
This meta-analysis of 632 adults with cancer found that home-based exercise rehabilitation incorporating cardiac rehabilitation principles w…
Home-based exercise programs using heart health principles can improve fitness and quality of life for adults living with cancer.
MOL-led WeChat and face-to-face intervention targets 30-day treatment in upper GI cancer
New Management Plan Aims to Speed Up Cancer Treatment
This cluster randomised controlled trial protocol will test whether a MOL-led management intervention using WeChat-based health education an…
A new trial plans to use WeChat and face-to-face talks to help patients with upper gastrointestinal cancer start treatment faster.
Fine-needle aspiration outperforms exfoliative cytology in pulmonary salivary gland-type tumors
Fine needle aspiration shows better accuracy for lung tumor diagnosis
This meta-analysis of 106 patients with primary pulmonary salivary gland-type tumors found cytohistologic concordance of 48.1%. Fine-needle …
Doctors are finding that fine needle aspiration provides more accurate results than other methods for identifying specific types of lung tum…
Circulating tumor DNA correlates with increased risk of aggressive disease progression and reduced overall survival
Circulating tumor DNA levels predict survival in multiple myeloma patients
This meta-analysis of 948 patients with multiple myeloma indicates that circulating tumor DNA (ctDNA) is associated with a higher risk of ag…
Detecting specific DNA fragments from tumors can help doctors identify patients with multiple myeloma who may face a more aggressive disease…
Brexucabtagene autoleucel achieves 88% overall response rate in relapsed or refractory mantle cell lymphoma
Trial Shows Brexucabtagene Autoleucel Provides Durable Benefit for Blood Cancers
This meta-analysis of 31 cohorts evaluates brexucabtagene autoleucel for relapsed or refractory mantle cell lymphoma and B-cell acute lympho…
Brexucabtagene autoleucel shows high response rates and durable benefits for adults with specific types of relapsed or refractory blood canc…
Lower phase angle values correlate with poorer clinical outcomes in patients with colorectal cancer
Lower Phase Angle Linked to Poorer Outcomes in Colorectal Cancer
This systematic review of observational studies indicates that lower phase angle (PhA) values are consistently associated with adverse clini…
Lower phase angle measurements may signal poorer nutritional status and higher risks of complications for patients with colorectal cancer.
Systemic barriers like delayed diagnosis and limited surgery impact survival in high-grade gliomas
Systemic Barriers Impact Survival for Patients with High-Grade Gliomas
This meta-analysis of 30 independent studies evaluates survival outcomes for high-grade gliomas in low- and middle-income countries. Finding…
Limited access to surgery, chemotherapy, and early diagnosis creates significant hurdles for patients with high-grade gliomas in developing …
Molecular testing reduces surgical resection rates for indeterminate thyroid nodules in Western and Asian cohorts
Molecular testing helps decide if surgery is needed for thyroid nodules
This meta-analysis of 127 studies evaluated the impact of molecular testing on surgical management and risk of malignancy for indeterminate …
Molecular testing can help doctors decide if surgery is necessary for thyroid nodules, showing different clinical roles in Western and Asian…
Metal stents provide longer time to recurrent biliary obstruction than plastic stents in malignant biliary obstruction
Metal stents may last longer for blocked bile ducts
This meta-analysis of six studies evaluated EUS-HGS with metal versus plastic stents for malignant biliary obstruction. Metal stents were as…
Metal stents can keep bile ducts open longer than plastic ones, but they may also carry a higher risk of complications.
All Oncology Articles
- MOL-led WeChat and face-to-face intervention targets 30-day treatment in upper GI cancer
- Fine-needle aspiration outperforms exfoliative cytology in pulmonary salivary gland-type tumors
- Molecular testing reduces surgical resection rates for indeterminate thyroid nodules in Western and Asian cohorts
- PFS and ORR fall short as OS surrogates in metastatic RCC
- Circulating tumor DNA correlates with increased risk of aggressive disease progression and reduced overall survival
- Metal stents provide longer time to recurrent biliary obstruction than plastic stents in malignant biliary obstruction
- Brexucabtagene autoleucel achieves 88% overall response rate in relapsed or refractory mantle cell lymphoma
- PD-1/PD-L1 inhibitors with anti-angiogenic drugs achieve 48% ORR in recurrent or metastatic nasopharyngeal carcinoma
- FOLFOXIRI plus cetuximab does not improve survival or response rates compared to bevacizumab in mCRC
- Lower phase angle values correlate with poorer clinical outcomes in patients with colorectal cancer
- Systemic barriers like delayed diagnosis and limited surgery impact survival in high-grade gliomas
- Home-based exercise rehabilitation may improve cardiorespiratory fitness and quality of life in cancer
- Sacituzumab tirumotecan shows manageable safety profile in metastatic triple-negative breast cancer
- Cancer patients exhibit significantly lower heart rate variability indices compared to age-matched controls
- Functionalized mesenchymal stem cells and exosomes show potential for anti-inflammatory effects in allergic rhinitis
- Dupilumab for Severe Pediatric Atopic Dermatitis Followed by Vitiligo Three Months Later
- Nanophotothermal systems using chitosan and hyaluronic acid provide real-time monitoring and multi-functional drug delivery
- Intravesical drug delivery systems improve urothelial drug deposition and allow repurposing of systemic agents
- Tonsillar metastasis in hepatocellular carcinoma patients may present as undifferentiated carcinoma with specific IHC markers
- Elevated serum uric acid levels correlate with improved overall survival in nasopharyngeal carcinoma
- Multidisciplinary therapy and immune checkpoint inhibitors achieve complete remission in a NUT midline carcinoma case
- Surgical resection of a rare lipoblastoma-like tumor of the tongue showed no recurrence at 19 months
- FDA Approves Lenvima (lenvatinib) for Radioactive Iodine-Refractory Differentiated Thyroid Cancer
- PSMA PET/CT shows higher sensitivity than mpMRI for detecting pelvic lymph node metastases in prostate cancer
- Comparative Efficacy of Modified FOLFIRINOX and Gemcitabine plus Nab-paclitaxel in Pancreatic Cancer
- Trastuzumab and tislelizumab show lower probability of health-related quality of life deterioration in gastric cancer
- Artificial intelligence and transformer-based architectures are emerging as key tools in breast cancer research
- Clinicoradiomics models provide superior and more consistent performance for predicting microvascular invasion in hepatocellular carcinoma
- Virtual reality interventions significantly reduce anxiety scores in patients with various types of cancer
- Approximately 40% to 55% of patients with advanced melanoma exhibit primary resistance to PD-1 monotherapy
- Colorectal cancer organoid technologies offer potential for individualized medication guidance and novel target discovery
- Structured exercise-based interventions reduce depressive symptoms in adults with lung cancer
- CAR-T in solid tumors: 13% ORR, 63% DCR, lymphopenia most common AE
- Breast cancer mortality in older US adults declines but slowdown after 2014 and disparities persist
- Structured Exercise Linked to Better Survival in Adults With Cancer
- Robotic gastrectomy shows no significant difference compared to laparoscopic gastrectomy for East Asian patients
- Innovative biomarkers and point-of-care tools offer non-invasive alternatives to traditional orthodontic treatment monitoring
- Non-vaccine immunotherapies show no survival advantage over vaccines in pediatric malignant brain tumors
- Androgen deprivation therapy is associated with an OR 1.34 for acute kidney injury
- FDA Approves Nubeqa (darolutamide) for Non-Metastatic Castration-Resistant and Metastatic Castration-Sensitive Prostate Cancer
- GCC Consensus Defines 75% Agreement Threshold for Advanced Endometrial Cancer Care
- Contrast-enhanced ultrasound shows 0.95 accuracy in distinguishing malignant from benign renal masses
- High CALLY index correlates with improved survival in hepatobiliary and pancreatic malignancies
- Immune dysfunction involving multiple cell types creates an immunosuppressive microenvironment in clear cell renal cell carcinoma
- Piperacillin treatment resolves symptoms and normalizes inflammatory markers in a case of prostatic malakoplakia
- Immune Checkpoint Inhibitors Combined With Chemotherapy Improve Pathological Complete Response in TNBC
- Multimodal treatment and surgical resection manage ameloblastic carcinoma with no recurrence at 6 months
- AENK-T cell fate is determined by specific receptor emergence and transcriptomic axes during exhaustion
- Immune cells and bone lineage cells interact via cytokines to modulate bone homeostasis in musculoskeletal disorders
- Polygenic methylation patterns are linked to osimertinib resistance in non-small cell lung cancer
- Ovarian function recovery in premenopausal women after chemotherapy remains modest despite improvement over 60 months
- Ileal neobladder provides superior nighttime continence and fewer early complications compared to sigmoid neobladder
- Adaptive Phase I/II designs for drug combinations remain methodologically diverse but rarely implemented
- Sintilimab Combined With Chemotherapy Improves Outcomes in Advanced Gastroesophageal Cancer
- HER2-positive invasive ductal carcinoma was identified in a patient with Neurofibromatosis type 1
- Exergaming shows favorable outcomes for mobility, balance, and fatigue in adults with cancer
- FDA Approves Ibtrozi (taletrectinib) for ROS1-Positive Non-Small Cell Lung Cancer
- High-throughput omics approaches identify biomarkers for myocarditis, pneumonitis, and colitis in ICI patients
- DOACs prescribed in 89.6% of cases following treatment discontinuation in cancer-associated thrombosis
- Psychosocial Interventions Improve Neurocognitive, Psychological, and Quality-of-Life Outcomes in Children With Cancer
- Percutaneous microwave ablation under ultrasound guidance achieves 86.0% clinical cure rate at 6 months
- Weekly Cisplatin Regimen Shows Noninferiority to Standard Dosing in Head and Neck Cancer
- MITF E318K variant associated with significantly increased melanoma risk and high nevus burden
- Early Palliative Care Improves Quality of Life and May Extend Survival in Cancer
- Moxibustion and auricular acupressure significantly reduce cancer-related fatigue in lung cancer patients
- OCT and fluorescence-guided imaging show highest clinical translation among biophotonic methods in veterinary medicine
- Semaglutide weight loss is greater in females and those with a hungry gut phenotype
- Melanoma Immunoediting Review Maps Elimination, Equilibrium, Escape and Drivers of Immunotherapy Resistance
- Dermatomyositis with breast cancer regresses on glucocorticoids and paclitaxel in single case
- NALIRIFOX shows no significant difference in overall survival compared to FOLFIRINOX in pancreatic cancer
- PARP inhibitor maintenance improves progression-free survival in advanced ovarian cancer with HRD-positive status
- Medial cavernous sinus wall resection achieves 85% endocrine remission in functioning pituitary adenomas
- Metabolic reprogramming of macrophages drives pro-fibrotic polarization in patients with Idiopathic Pulmonary Fibrosis
- Multifaceted mechanisms including replication fork stabilization and epigenetic reprogramming drive PARP inhibitor resistance in ovarian cancer
- SGRT and OSMS assisted DIBH reduces heart and LAD doses in left-sided breast radiotherapy
- TMB and TILs show no clear association with second primary cancer in resected NSCLC
- Psychological, social, and behavioral barriers and facilitators influence prehabilitation adherence in cancer patients before surgery
- Tumor necrosis-related fever may occur during neoadjuvant chemoimmunotherapy for metaplastic breast carcinoma
- SMMI framework provides a conceptual model for risk stratification in high-risk oral potentially malignant disorders
- 5-year colonoscopy interval shows noninferiority to 3-year interval for colorectal cancer incidence
- Blinatumomab Improves Four Year Event Free Survival in Pediatric High Risk B Cell ALL
- Virtual reality technology may alleviate perioperative anxiety and pain in breast cancer patients
- Laparoscopic right hemicolectomy for ascending colon cancer with situs inversus totalis
- Distinct microbial taxa and functional pathways are associated with oral squamous cell carcinoma
- Idiopathic premature adrenarche is associated with higher body mass index and insulin resistance markers
- Oncoplastic breast-conserving surgery reduces risk of initial positive margins and margin-related reoperations in breast cancer
- Autoimmune gastritis and pernicious anemia are associated with increased risks of gastric neoplasms
- Prehabilitation reduces early urinary incontinence and improves quality of life after radical prostatectomy
- Exosomal miRNAs Show High Diagnostic Accuracy for Hepatocellular Carcinoma
- Lenvatinib plus pembrolizumab yields 28-month survival in BRAF wild-type anaplastic thyroid cancer
- Trastuzumab Deruxtecan Management of HER2 Positive Metastatic Breast Cancer with Visceral Crisis
- PIWIL4 exhibits context-dependent roles in cancer progression and metabolic reprogramming across various cancer types
- Self-administered ivermectin and fenbendazole in a patient with metastatic melanoma showed mixed radiographic and ctDNA responses
- MDT-guided perioperative strategy and staged anticoagulation manage pancreatic cancer in a patient with Moyamoya disease
- Nodal staging in upper eyelid Merkel cell carcinoma may influence disease-free status and survival outcomes
- Hamburg Life After Cancer Program protocol aims to improve quality of life in cancer survivors
- Rezvilutamide plus ADT with efavirenz-based ART yields PSA decline in one HIV-positive mHSPC patient
- Divide-Survive Matrix decouples proliferation from survival architecture in tumor assessment
- PPSS shows rapid metastatic progression despite neoadjuvant Adriamycin, Ifosfamide, and Mesna
- Spatial immune-ecology framework proposed for gastric and GEJ adenocarcinoma ICI selection
- FDA-approved AI solutions for cancer histopathology are limited to a narrow range of applications
- Gut-lung axis in lung cancer: soluble metabolites lead, neural pathways remain hypothetical
- Lipid metabolism reprogramming emerges as key mechanism of endocrine resistance in ER+ breast cancer
- Sex and gender-tailored screening strategies aim to address disparities in colorectal cancer detection and participation
- Splenic hilum nodal involvement is rare in pancreatic body adenocarcinoma with a 1.1% prevalence
- Low inferior mesenteric artery ligation does not significantly impact survival in rectosigmoid cancer patients
- Hypoxia-inducible factor 1 alpha promotes aggressive phenotypes and treatment resistance in cervical cancer
- MRI-based radiomics models achieve 0.91 AUC for predicting GPC3 expression in hepatocellular carcinoma
- High Dietary Inflammatory Potential Correlates with Increased Risk of Oral Cancer
- FDA Approves Hyrnuo (zongertinib) for HER2 TKD Mutant Non-Squamous NSCLC After Prior Therapy
- Gut microbiome composition correlates with clinical outcomes in hepatocellular carcinoma patients treated with immune checkpoint inhibitors
- Encorafenib and Binimetinib Combination Therapy for Patients with BRAF Mutated Cutaneous Melanoma
- Alemtuzumab-based therapy achieves 81.9% response rate in adult T-cell prolymphocytic leukemia
- Thoracic Radiotherapy Linked to 7.6% Pooled Incidence of Reported Atrial Fibrillation
- HER2-low breast cancer shows distinct survival trajectories versus HER2-positive in systematic review
- Minimally invasive nipple-sparing mastectomy reduces surgical trauma and postoperative complications in breast cancer patients
- Gut Microbiome and Metabolites May Modulate Thyroid Cancer Immunity and Treatment Response
- Trial protocol evaluates 9-month ADT plus ARTA for high-risk prostate cancer non-inferiority
- Triple Combination Therapy Improves Progression-Free Survival in Patients with Hepatocellular Carcinoma
- Ivonescimab Combined With Chemotherapy Improves Progression Free Survival in EGFR Mutated NSCLC
- Dose Escalated Radiotherapy Combined With Androgen Deprivation Improves Outcomes in High Risk Prostate Cancer
- Evaluating AI and Manual Stromal Immune Cell Quantification in HER2 Positive Breast Cancer
- Empowered Survivor digital tool boosts self-efficacy in oral cancer survivors
- Physical exercise during neoadjuvant chemotherapy does not significantly improve pathologic complete response in solid tumors
- BRCA1 or BRCA2 mutations correlate with improved survival and platinum sensitivity in ovarian cancer
- D-dimer elevated in high-risk multiple myeloma with pooled SMD of 1.60
- SCRT plus ICI associated with higher CR and pCR rates than LCRT in rectal cancer
- Hypofractionated whole-breast irradiation is associated with the lowest ipsilateral breast recurrence rates in early-stage breast cancer
- PD-1/PD-L1 inhibitor plus chemotherapy improves overall survival in advanced gastric and esophageal junction cancer
- Most oncology professionals lack prior training in integrative medicine despite emerging curriculum needs
- Bidirectional crosstalk between hepatic stellate cell-derived CAFs and T cells drives immune evasion in HCC
- Ki-67 index increased from 15% to 70% in a recurrent intracranial solitary fibrous tumor
- Sutureless renorrhaphy is noninferior to conventional renorrhaphy for trifecta achievement in robot-assisted partial nephrectomy
- Meridian Sinew Tuina significantly reduces upper limb circumference and pain in breast cancer-related lymphedema
- Single-fraction stereotactic radiosurgery shows marginally higher 6-month local control than hypofractionated stereotactic radiotherapy
- Non-invasive treatments and advanced imaging offer effective, low-complication management for seborrheic keratosis
- Objective response rate correlates with overall survival in nivolumab-containing regimens for metastatic melanoma
- Robotic-assisted bronchoscopy provides comparable diagnostic yield to CT-guided biopsy for peripheral pulmonary lesions
- AI-derived nomograms outperform conventional markers for risk stratification and prognosis in neuroblastoma
- Bispecific antibodies improve progression-free survival and overall survival in patients with solid tumors
- Disitamab vedotin and camrelizumab achieved durable remission in a patient with metastatic gastric cancer
- Insufficient evidence exists to determine the independent clinical contribution of GM-CSF to anti-GD2 immunotherapy
- Nab-paclitaxel, cisplatin, and pembrolizumab achieved pathologic complete response in a patient with small cell lung cancer
- ICIs Boost pCR in Early Triple-Negative Breast Cancer
- Evaluating Chemoimmunotherapy versus Monotherapy for Advanced NSCLC Patients with High PD-L1 Expression
- SGLT2 inhibitors not tied to gastrointestinal cancer risk in type 2 diabetes meta-analysis
- CLDN18.2 expression prevalence of 33.99% in patients with gastric and gastroesophageal junction adenocarcinoma
- Long-term exercise significantly attenuates cardiac troponin I elevation in anthracycline-treated breast cancer patients
- Shear Wave Elastography Shows Promise in Predicting Breast Cancer Response
- Plant-derived bioactive compounds may offer neuroprotective effects and alleviate late-life depression in older adults
- Post-translational modifications drive drug resistance in hepatocellular carcinoma, systematic review finds
- FDA Approves Etopophos (etoposide phosphate) for Refractory Testicular Tumors and Small Cell Lung Cancer
- FDA Approves Fyarro (nab-sirolimus) for Malignant PEComa
- Neurosurgical management is essential for rare cerebral metastases from non-DES-related vaginal clear cell adenocarcinoma
- Impact of Lifestyle and Nursing Interventions on Quality of Life in Gynecologic Cancers
- EGFR-TKI plus anti-angiogenic therapy shows HR 0.63 for overall survival in NSCLC with brain metastases
- Adherence to clinical practice guidelines improves survival for Stage II and III colon cancer
- Pharmacokinetically guided 5-fluorouracil dosing reduces severe toxicity and improves response rates in colorectal cancer
- Endoscopic techniques like ESD and EMR offer distinct advantages for early colon cancer management
- AI-enabled D-dimeromics may identify ultra-high-risk breast cancer phenotypes for individualized treatment
- FDA Approves Bavencio (avelumab) for Metastatic Merkel Cell Carcinoma
- FDA Approves Unloxcyt (cosibelimab-ipdl) for Advanced Cutaneous Squamous Cell Carcinoma
- FDA Approves Imjudo (tremelimumab) for Unresectable Hepatocellular Carcinoma and Metastatic NSCLC
- FDA Approves Penpulimab-kcqx for Non-Keratinizing Nasopharyngeal Carcinoma
- FDA Approves Loqtorzi (toripalimab-tpzi) for Nasopharyngeal Carcinoma
- Age and sex drive distinct immune microenvironment and evasion mechanisms in cancer patients
- Integrating immunohistochemistry with next-generation sequencing improves diagnosis and risk stratification for myxoid glioneuronal tumor
- High CAR-HEMATOTOX scores correlate with increased ICAHT odds and worse survival in CAR T-cell therapy
- Approximately 61% of cancer patients resume anticancer treatment after unplanned ICU admission
- Ketone Supplementation Improves Metabolic and Hormonal Profiles in PCOS
- Olaparib maintenance therapy significantly improves progression-free survival in advanced ovarian cancer patients
- Higher preoperative neutrophil-to-lymphocyte ratio predicts poorer survival in oral squamous cell carcinoma patients
- Machine learning models predict cancer symptoms with AUC values ranging from 0.76 to 0.86
- Viral hepatitis infections pose significantly higher risk for liver cancer than smoking-related lung cancer
- Durvalumab plus tremelimumab shows no significant overall survival benefit compared to durvalumab alone
- Locally advanced thyroid cancer is associated with increased rates of difficult airway and tracheal invasion
- Digital CBTi reduces insomnia severity scores more than telephone or group delivery methods
- Robotic-assisted endoscopic submucosal dissection achieves 98.2% en-bloc and 96.8% R0 resection rates in GI neoplasms
- UFT combined with radiotherapy achieves a 38% pooled objective response rate in advanced pancreatic cancer
- Lu-PSMA-617 combined with ADT and ARPI reduced radiographic progression risk by 28%
- FDA Approves Ziihera (zanidatamab-hrii) for HER2-Positive Gastroesophageal Adenocarcinoma and Biliary Tract Cancer
- Mezigdomide plus carfilzomib and dexamethasone improves progression-free survival to 18.0 months in multiple myeloma
- FDA Approves Tevimbra (tislelizumab-jsgr) for Esophageal and Gastric Cancers
- Belzutifan and Lenvatinib Combination Improves Progression Free Survival in Advanced Renal Cell Carcinoma
- Combined SHOX2 and RASSF1A methylation provides superior diagnostic performance for lung cancer detection
- DLL3-directed therapy shows early activity in biomarker-selected neuroendocrine prostate cancer cases
- Tele-robot-assisted prostatectomy achieves 100% technical success in small case series
- ctDNA-guided adjuvant immunotherapy improves survival outcomes in patients with muscle-invasive urothelial carcinoma
- Systemic therapies may complicate radiation-induced lung injury by sustaining inflammation or delaying repair
- Splicing-derived neoantigens provide diverse target classes for T-cell and antibody-based cancer immunotherapies
- Bioactive compounds from aromatic plants show potent cytotoxic activities in various preclinical cancer models
- MULTIPL biomarker identifies patients with significantly longer overall survival on gemcitabine plus nab-paclitaxel
- D-VCd improves hematologic CR rate to 59.5% compared to 19.2% in AL amyloidosis
- Ranibizumab port delivery system shows noninferior BCVA gains and low supplemental treatment requirements in diabetic retinopathy
- Zika virus oncolytic therapy provides significant pooled survival benefit in preclinical glioblastoma models
- HER2, PD-L1, MSI/MMR, and CLDN18.2 biomarkers may guide treatment selection in gastric cancer conversion therapy
- Paclitaxel and Cisplatin Combination Improves Outcomes in Locoregionally Advanced Nasopharyngeal Carcinoma
- Deep Learning algorithms demonstrate potential for diagnosing oral potentially malignant disorders and squamous cell carcinoma
- Radiomic Features Demonstrate High Diagnostic Accuracy for Predicting Ki-67 Expression in Hepatocellular Carcinoma
- Nicotine electronic cigarettes increase quit rates compared to nicotine replacement therapy and behavioral support